Showing results (1631-1640 of 1,659) with videos related to
Sort By:
Pageof 166
European Journal of Cancer (Oxford, England : 1990)|December 29, 2020
Survival outcomes of patients with advanced melanoma from 2013 to 2017: Results of a nationwide population-based registryM C T van Zeijl, L C de Wreede, A J M van den Eertwegh, et al.Research and Practice in Thrombosis and Haemostasis|August 22, 2022
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarinIngrid M Bistervels, Roisin Bavalia, Jan Beyer-Westendorf, et al.Cancers|April 25, 2020
Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted DrugsBrenda Leeneman, Carin A Uyl-de Groot, Maureen J B Aarts, et al.International Journal of Cancer|June 20, 2020
Real-world outcomes of advanced melanoma patients not represented in phase III trialsMichiel C T van Zeijl, Rawa K Ismail, Liesbeth C de Wreede, et al.ESMO Open|November 17, 2020
Lower risk of severe checkpoint inhibitor toxicity in more advanced diseaseRik J Verheijden, Anne M May, Christian U Blank, et al.Journal of Geriatric Oncology|May 22, 2021
Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment RegistryAnouk Jochems, Esther Bastiaannet, Maureen J B Aarts, et al.European Journal of Cancer (Oxford, England : 1990)|December 29, 2016
Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the NetherlandsAnouk Jochems, Maartje G Schouwenburg, Brenda Leeneman, et al.Cancers|July 21, 2019
Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment RegistryAnouk Jochems, Monique K van der Kooij, Marta Fiocco, et al.Clinical Kidney Journal|August 2, 2023
The ERA Registry Annual Report 2020: a summaryMegan E Astley, Rianne Boenink, Samar Abd ElHafeez, et al.Melanoma Research|May 12, 2018
Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomesMaartje G Schouwenburg, Anouk Jochems, Brenda Leeneman, et al.Pageof 166